Inhibitory receptors (IRs) are pivotal in controlling T cell homeostasis because of their intrinsic regulation of conventional effector T (T conv ) cell proliferation, viability, and function. However, the role of IRs on regulatory T cells (T regs ) remains obscure because they could be required for suppressive activity and/or limit T reg function. We evaluated the role of lymphocyte activation gene 3 (LAG3; CD223) on T regs by generating mice in which LAG3 is absent on the cell surface of T regs in a murine model of type 1 diabetes. Unexpectedly, mice that lacked LAG3 expression on T regs exhibited reduced autoimmune diabetes, consistent with enhanced T reg proliferation and function. Whereas the transcriptional landscape of peripheral wild-type (WT) and Lag3-deficient T regs was largely comparable, substantial differences between intra-islet T regs were evident and involved a subset of genes and pathways that promote T reg maintenance and function. Consistent with these observations, Lag3-deficient T regs outcompeted WT T regs in the islets but not in the periphery in cotransfer experiments because of enhanced interleukin-2-signal transducer and activator of transcription 5 signaling and increased Eos expression. Our study suggests that LAG3 intrinsically limits T reg proliferation and function at inflammatory sites, promotes autoimmunity in a chronic autoimmune-prone environment, and may contribute to T reg insufficiency in autoimmune disease.
INTRODUCTION
Inhibitory receptors (IRs) are pivotal in controlling and shaping the host immune response. Insufficient coinhibition can lead to the breakdown of self-tolerance, whereas chronic use of inhibitory pathways constitutes a major barrier to effective antitumor immunity (1) (2) (3) . Tumor-infiltrating lymphocytes up-regulate multiple IRs and exhibit an exhausted T cell phenotype as a consequence of chronic antigen stimulation (3) . Recent clinical trials have highlighted the therapeutic benefit of IR blockade, called checkpoint inhibition (e.g., anti-CTLA4, anti-PD1, and anti-PD-L1) (2, 3) . However, not all patients benefit from this, leading to speculation that compensatory mechanisms may be elevated in nonresponders and that additional IRs may need to be blocked. Lymphocyte activation gene 3 (LAG3) is the most recent IR to be targeted in the clinic.
LAG3 is expressed on activated T cells, intrinsically limiting conventional T (T conv ) cell proliferation, expansion, and viability (4) (5) (6) (7) . LAG3 is required for maintaining self-tolerance in an autoimmune-prone environment (1, 8) . Mice on the nonobese diabetic (NOD) background deficient in Lag3 exhibit accelerated autoimmune diabetes with 100% penetrance (8) . In contrast, LAG3 contributes to tumor-mediated immunosuppression and promotes tumoral immune escape (9, 10) . Although LAG3 blockade or deficiency alone only has a minimal effect on tumor growth in mouse models, combinatorial PD1 blockade or deletion leads to tumor clearance (9) . LAG3, as well as other IRs, are also highly expressed on regulatory T cells (T regs ) (11) (12) (13) (14) , a critical suppressive subpopulation of T cells that prevents autoimmunity but limits antitumor immunity (15, 16) . This complicates the analysis of studies using Lag3 −/− mice or LAG3 blocking antibodies and limits the dissection of IR function on different T cell populations. Previous studies have suggested that LAG3 was used as a mechanism for T reg suppression (11) (12) (13) 15) . However, it is also possible that LAG3 may intrinsically limit T reg function in a manner commensurate to its role on other T cell populations. This ambiguity complicates defining the role of LAG3, and perhaps other IRs, on T regs , assessing whether differential IR expression on T regs affects the progression of autoimmune disease and interpreting the mechanistic basis of LAG3 blockade in mouse models and patients with cancer.
Because the activity of T regs is likely to be near maximal in tumors (17) , the full impact of LAG3 deficiency on T reg function and viability may not be evident in tumor models. Thus, we chose to assess T reg function in a model in which their activity delays disease onset but is ultimately insufficient (18) . Several studies have shown that T regs ultimately lose stability and function in an autoimmune-prone environment (19) (20) (21) (22) . To assess the function of LAG3 on T regs , we generated mice that specifically lack LAG3 on Foxp3 + T regs and assessed their proliferation and function in a mouse model of autoimmune diabetes. These mice exhibited reduced autoimmune diabetes due to enhanced T reg proliferation and function in islets. The expression of LAG3 on T regs may limit T reg proliferation and function by down-regulating Eos and the interleukin-2 (IL-2)-signal transducer and activator of transcription 5 (STAT5) pathway by reducing CD25 expression.
RESULTS

Intra-islet T regs constitutively express LAG3
To assess the role of LAG3 on T regs , we used the NOD mouse model of type 1 diabetes (23) . We first assessed the expression of LAG3, as well as other IRs, on islet-infiltrating T cells using transcriptional analysis 2 of 10 and flow cytometry. Multiple IRs were transcriptionally up-regulated in intra-islet T regs compared with peripheral T regs (Fig. 1A) . LAG3 was substantially up-regulated on islet-infiltrating T regs compared with peripheral T regs in NOD mice, and the percentage of LAG3 + T regs was also higher than the percentage of LAG3 + CD4 + and CD8 + T conv cells (Fig. 1, B to D, and fig. S1 ), suggesting a role for LAG3 on T regs .
The absence of LAG3 on T regs results in reduced autoimmune diabetes
To assess the importance of LAG3 expression on T regs in controlling autoimmune diabetes, we generated Lag3 L/L-YFP conditional knockout reporter mice (backcrossed to NOD/ShiLtJ for 12 generations; see Materials and Methods) that lack cell surface expression of LAG3 and thus cannot mediate signaling but continue to release soluble LAG3 (24, 25) , specifically on T regs , when crossed with the Foxp3
Cre-GFP . NOD mice ( Fig. 2A and fig. S2 ). Although there is no evidence that soluble LAG3 affects T cell function (24, 25) , we took this approach to avoid this complication. This mutant mouse also incorporated an internal ribosomal entry site (IRES)-yellow fluorescent protein (YFP) cassette inserted into the 3′ untranslated region (UTR) as a reporter of Lag3 promoter activity ( Fig. 2A) . We initially crossed Lag3 L/L-YFP .NOD mice with Cd4
Cre .NOD mice to assess the phenotype after global loss of surface LAG3 on all T cells (Fig. 2B and fig. S2 , B and C). Loss of LAG3 surface expression on all CD4 + and CD8
Cre .NOD) resulted in a markedly accelerated onset of autoimmune diabetes with 100% penetrance by 12 weeks of age, which phenocopied our observations with Lag3 −/− .NOD mice and suggested that the dominant function of LAG3 was restricted to T cell populations (Fig. 2B) (8) .
Because LAG3 has been shown to be required for optimal T reg function (11) (12) (13) 15) , we reasoned that the accelerated autoimmune diabetes observed in the Lag3
Cre .NOD mice might be partially due to the loss of LAG3 expression on T regs .
We then assessed the impact of the loss of LAG3 surface expression on T regs by analyzing Lag3
Cre-GFP .NOD mice had a significantly delayed onset of autoimmune diabetes, decreased diabetes incidence (48% versus 84%) by 30 weeks of age, and male Lag3
Cre-GFP .NOD mice were completely protected from autoimmune diabetes (Fig. 2C) . Although we only assessed a small number of cohoused female Lag3
Cre-GFP .NOD littermates, their diabetes incidence was 60%, suggesting that LAG3 exhibits haploinsufficiency. Although the absence of LAG3 on T regs did not affect the degree of insulitis at 6 weeks of age, it led to a significant reduction at 10 weeks of age in female and male Lag3
Cre-GFP .NOD mice (Fig. 2D) , suggesting that the expression of LAG3 on T regs had little impact on the initiation of islet infiltration but was critical to limit T reg -mediated self-tolerance and the onset of autoimmune diabetes. Together, these data suggest that LAG3 may limit T reg -mediated suppression of autoimmunity.
Consistent with the reduced insulitis and diabetes observed, there were reduced numbers of CD4 Nonparametric Mann-Whitney test was used in (C). *P < 0.05, **P < 0.01. Percent of islets 
Cre-GFP .NOD .NOD mice together with co-caged controls at 6 and 10 weeks of age (n = 4 to 7). Horizontal black bars indicate the mean. Error bars indicate SEM. The log-rank test was applied to Kaplan-Meier survival function estimates to determine the statistical significance in (B) and (C), and nonparametric Mann-Whitney test was used in (D). ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
of Lag3
Cre-GFP .NOD mice compared with controls, suggesting that Lag3-deficient T regs may not selectively suppress specific subpopulations of diabetogenic T cells but rather globally affect all islet-infiltrating cells ( fig. S3B ). This observation may have been anticipated given that we have previously shown that only islet antigenreactive T cells can enter the islets (26) . The reduced number of T conv cells in the islets of Lag3
Cre-GFP .NOD mice was due to the decreased CD8 + T cell proliferation [assessed by Ki67 expression and 5-bromo-2′-deoxyuridine (BrdU) incorporation] and reduced expression of the antiapoptotic factor Bcl2 (27) (28)], and proliferation of Lag3-deficient and wild-type (WT) T regs were comparable, Lag3-deficient T regs expressed a higher level of the antiapoptotic factor Bcl2 in the islets (figs. S5 and S7A). Inducible T cell costimulator (ICOS, CD278), which has been shown to be critical for T reg homeostasis and functional stability in NOD mice (29) , was also up-regulated on intra-islet T regs in the absence of LAG3 ( fig. S7A ). The expression of multiple IRs [programmed cell death protein 1 (PD1), T cell immunoreceptor with Ig and ITIM domains (TIGIT), and T cell immunoglobulin and mucin-domain containing 3 (TIM3)] was slightly enhanced on Lag3-deficient T regs ( fig. S7A ), inferring a cell-intrinsic process in T regs to compensate for the loss of LAG3. However, the suppressive capacity of intra-islet and peripheral WT and Lag3-deficient T regs in an in vitro microsuppression assay was comparable on a per-cell level ( fig. S7B ). Overall, these data suggest that Lag3-deficient T regs appear to have an enhanced impact on islet antigen-reactive T cell proliferation, effector cytokine production, and probably viability (as suggested by Bcl2 expression) in vivo, perhaps at the population level as a result of their enhanced proliferative and survival capacity.
LAG3 affects the T reg transcriptome
To assess the impact of LAG3 deletion on the T reg cell transcriptome, we performed RNA sequencing (RNA-seq) of WT and Lag3-deficient T regs from the islets and nondraining lymph nodes (ndLN). The whole-genome expression profiles, as well as the expression of previously defined T reg signature genes (30, 31) , were affected by the islet microenvironment ( Fig. 1A and fig. S8 ). A substantial number of genes and pathways were modulated by the loss of LAG3 expression of T regs in the islets (Fig. 3A, fig. S9 , and table S1). A group of genes were down-regulated in intra-islet WT but not in Lag3-deficient T regs , compared with peripheral T regs (Fig. 3A and fig. S10 ), suggesting that these genes might be required for optimal T reg function or survival and that LAG3 was limiting their expression in intra-islet T regs .
One of these genes was Ikzf4 (Eos), a corepressor of Foxp3 that prevents the expression of T conv genes in T regs (Fig. 3A and fig. S10 ) (31) (32) (33) (34) . The expression profile of intra-islet WT T regs resembled the previously published transcriptional signature in Ikzf4-knockdown T regs , whereas the expression profile of intra-islet Lag3-deficient T regs resembled the transcriptional signature in mock control T regs (Fig. 3,  A and B) (32) . These data suggest that LAG3 might limit Eos expression and thus the function and maintenance of intra-islet T regs . IL-2 has been shown to be essential for T reg cell maintenance, whereas defective IL-2 signaling in T regs triggers autoimmune islet destruction (22, 35, 36) . Genes modulated by IL-2-STAT5 signaling were substantially enhanced in the absence of LAG3 on T regs (Fig. 3 , C and D, and table S1). Overall, the transcriptome analyses suggest that LAG3 negatively regulates intra-islet T regs by down-regulating key genes and pathways that are essential for T reg maintenance and function.
LAG3 intrinsically limits T reg proliferation
To directly assess whether Lag3-deficient T regs had a proliferative advantage over WT T regs and to determine whether the pathways identified by transcriptome analysis were intrinsically regulated by LAG3 in T regs , we cotransferred an equal number of activated congenic markermismatched WT (Thy1. (Fig. 4A) . Both WT and Lag3-deficient donor T regs were sorted from mice that expressed the islet antigenspecific BDC2.5 T cell receptor (TCR), which facilitates islet entry (26, 37) . Foxp3 expression was not altered in either T reg population after adoptive transfer (fig. S11, A and B), suggesting that LAG3 may not affect T reg stability. Lag3-deficient T regs outcompeted WT T regs in the islets (60% versus 40%, respectively) and in the pancreatic lymph node (PLN) (54% versus 46%, respectively), but not in the periphery (Fig. 4 , B and C).
Previous studies have shown that reduced CD25 and Bcl2 levels cause a decline in intra-islet T reg viability, whereas administration of low-dose IL-2 promotes Bcl2 expression and T reg survival (22, 38, 39) . A higher percentage of intra-islet Lag3-deficient T regs expressed Ki67 and Bcl2 compared with WT T regs (Fig. 4, D and E, and fig. S11C ). Although differences were also observed in the periphery in these cotransfer experiments, these were probably due to the activation of T regs in vitro before adoptive transfer. Consistent with the transcriptomic analysis, Lag3-deficient T regs exhibited higher CD25 expression and STAT5 phosphorylation compared with WT T regs (Fig. 4, F and G, and fig.  S11C ). Furthermore, Eos (Ikzf4) expression was reduced in WT but not in Lag3-deficient intra-islet T regs compared with peripheral T regs , whereas another Ikaros family member, Helios (Ikzf2), was unaffected by LAG3 expression (Fig. 4, H and I, and fig. S11C ).
Last, to determine whether LAG3 modulated Eos expression and whether direct modulation of Eos levels affected T reg proliferation, we first assessed Eos levels in WT and Lag3-deficient T regs after stimulation in vitro. As anticipated from our transcriptomic analysis, Lag3-deficient T regs expressed more Eos after stimulation than WT T regs (Fig. 5) . Likewise, activated Lag3-deficient T regs exhibited increased proliferation, as measured by BrdU incorporation, over WT T regs . Knockdown of Ikzf4 in Lag3-deficient T regs reduced Eos expression and their proliferative capacity, whereas overexpression of human IKZF4 in WT T regs enhanced their proliferation (Fig. 5 and fig. S12 ). Together, these data support a model in which LAG3 intrinsically limits T reg proliferation and viability by modulating pathways that are critical for T reg function and proliferation, particularly the IL-2-STAT5 and Eos pathways.
DISCUSSION
Our study supports a model in which the IR LAG3 intrinsically limits T reg proliferation and functionality by repressing pathways that promote the maintenance of T regs at inflammatory sites. Lag3-deficient T regs do not appear to have increased suppressive capacity on a per-cell basis. However, they do have an enhanced proliferative and survival advantage that potentiates their suppressive capacity at the population level and endows them with a critical advantage over time. As the disease progresses, subtle changes in Lag3-deficient T regs allow them to accumulate over time, leading to a substantial impact on the development of chronic autoimmune diabetes. It is remarkable that this small, T reg -restricted genetic alteration renders male NOD mice resistant to diabetes and substantially limits autoimmune diabetes in female mice, whereas LAG3 deletion in all T cell subsets markedly accelerates the disease. Thus, in autoimmune environments where chronic inflammation dominates, LAG3 may be constitutively expressed on T regs , thereby limiting their capacity to block the function of diabetogenic T cells and prevent autoimmune diabetes. This raises the possibility that constitutive IR expression on T regs may underlie their insufficiency in autoimmune disease. It is also possible that in creased or constitutive LAG3 expression on T regs may also limit their suppressive capacity in inflammatory or infectious diseases where increased tissue damage or pathology is observed.
The onset and incidence of autoimmune diabetes is affected by sex hormones (40, 41) . Our transcriptomic analysis suggested that some sex hormone-related pathways were affected by the presence or absence of LAG3 on T regs (table S1 ). This may partially explain the differences observed between female and male NOD mice that had Lag3-deficient T regs , suggesting that there may be additional noncanonical roles for LAG3 in modulating immune responses.
The impact of IRs on T reg function and maintenance has been controversial. It was reported that the absence of PD1 on T regs led to the generation of ex-Foxp3 T cells (42) . However, Foxp3 stability was maintained in the absence of LAG3 on T regs , suggesting that distinct pathways are regulated by LAG3 in T regs . Although our observations here do not preclude a role for LAG3 as a mechanism of T reg suppression (11) (12) (13) 15) , our data point to a dominant role for LAG3 in limiting T reg maintenance and proliferation. This may be mediated in part by the Foxp3 corepressor Eos, which is required for T reg maintenance (32, 33) . There seemed to be a direct correlation between Eos expression and T reg proliferation because both were increased after stimulation of Lag3-deficient 
Foxp3
Cre-GFP BDC2. . Nonparametric Mann-Whitney test was used in (C) to (I). **P < 0.01, ***P < 0.001, and ****P < 0.0001.
T regs , and the overexpression or knockdown of Eos resulted in analog alterations in T reg proliferation (Fig. 5) . Furthermore, enhanced IL-2-STAT5 signaling has been shown to promote T reg maintenance and survival (22, 35, 36, 38, 39 ). LAG3 appears to limit this pathway, thereby having a global impact on T reg function. Future studies may shed light on two further questions: (i) Do other IRs promote or limit T reg function, proliferation, and/or survival? (ii) Do these IRs affect these T reg parameters using comparable or distinct mechanisms? These observations highlight the differential impact of LAG3 modulation on different T cell populations in vivo, where LAG3 modulation alleviates or exacerbates disease depending on whether T reg or T conv cells are targeted. The impact of losing LAG3 on T regs leads to enhanced immunosuppression and therefore may offset the effect of blocking the LAG3 pathway in T conv cells. One wonders whether this might underlie the lack of efficacy observed on tumor growth with LAG3 blockade (9) . These findings may also apply to other IRs (4, 14) , whose intrinsic effect on T regs might have been previously overlooked. Our findings may have clinical relevance in that patients who fail to respond to checkpoint blockade immunotherapy may do so because it has a greater impact on promoting T reg function than mitigating T conv cell exhaustion. Thus, the differential impact of immunotherapy may be modulated by the T conv / T reg cell ratio and/or IR expression on different T cell subsets. Given that anti-LAG3 has entered phase 1 clinical trials for multiple tumor types with the goal of enhancing the efficacy of PD1 blockade, we should consider the differential impact this might have on T reg function and survival versus T conv cell exhaustion as well as the strategies that specifically target checkpoints on T conv cells or T regs to boost antitumor immunity or mitigate autoimmunity, respectively.
MATERIALS AND METHODS
Mice and study design NOD/ShiLtJ (stock #001976), Thy1.1 (stock #004483), and BDC2.5 (stock #004460) NOD mice were purchased from the Jackson Laboratory. Mice of different groups were cohoused and randomly assigned to analyses. Ten to 20 mice per group were used in diabetes incidence studies and followed up to 30 weeks of age. Three to five age-matched female mice per group were used in each analytical experiment, and two to four independent experiments were repeated. Three 8-week-old female mice per group were pooled and used in RNA-seq analyses, and three independent experiments were repeated. The genotypes were not blinded, except for the insulitis scoring. All data points were presented.
Generation of Lag3
L/L-YFP mice A 5.7-kb Xba I-Sal I fragment (5′ arm of homology) corresponding to exon 6 and the intronic region between exons 5 and 6 and a 4.1-kb Cla I-Eco RI fragment (3′ arm of homology) containing the polyA site (pA) were generated by polymerase chain reaction from C57BL/6J genomic DNA and cloned into pSP73. A fragment corresponding to exon 7 (containing the CP cleavage site and flanked by loxP sites) and exon 8 was inserted between the two homologous arms. An IRES-YFP fragment was inserted between the Lag3 stop codon and the pA. Just after the pA, an frt-flanked neomycin-positive selection cassette (FrtNeo) was inserted. To increase the frequency of homologous recombination and reduce nonspecific integration, we cloned a diphtheria toxin cassette (DT-A) upstream of the 5′ homologous arm. The resulting plasmid was linearized with Ssp I and electroporated into E14 embryonic stem cells. After selection with G418, resistant clones were screened by Southern blot analysis, sequenced, and injected into blastocycts, and the resulting chimeras were bred to C57BL/6J for germline transmission. The mice were backcrossed 12 generations onto the NOD background and tested by microsatellite analysis. All 20 Idd loci were covered by 144 SNPs in the microsatellite test (45) , and all tested SNPs were NOD.
Measurement of diabetes and insulitis
Diabetes and insulitis were assessed as previously described (8, 46) . Briefly, diabetes incidence was monitored weekly by testing for the presence of glucose in the urine with Diastix (Bayer). Mice positive by Diastix were then bled and tested with a Breeze2 glucometer (Bayer). Mice were considered diabetic if the blood glucose level was ≥400 mg/dl.
Pancreata were embedded in a paraffin block and cut into 4-m-thick sections at 150-m step sections and stained with hematoxylin and eosin. Pancreata collected at SJCRH were processed at the Veterinary Pathology Core of SJCRH, and pancreata collected at UPSOM were repeated in the same way at the Histo-Scientific Research Laboratories Cre-GFP .NOD; NTC, nontargeting control vector; EV, empty vector pMIA. Horizontal black bars indicate the mean. Fisher's LSD test was applied to one-way ANOVA to determine the statistical significance. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
(HSRL Inc.). An average of 60 to 80 islets per mouse were scored in a blinded manner. Two methods of insulitis measurement were used as previously described (46) .
Islet isolation and lymphocyte preparation
Islets were isolated as previously described (26) . Briefly, the pancreata were perfused with 3 ml of collagenase type 4 (Worthington) through the pancreatic duct and incubated in 3 ml of collagenase [600 U/ml in Hanks' balanced salt solution (HBSS) with 10% fetal bovine serum (FBS)] for 30 min at a 37°C water bath. The pancreata were then distributed and washed twice with HBSS (Corning) with 10% FBS. The islets were picked under a dissecting microscope, distributed with 1 ml of cell dissociation buffer (Life Technologies), and incubated for 15 min at 37°C with vortexing every 5 min. After a final wash, the cells were resuspended, counted, and used. Surface staining was performed on ice for 15 min. For cytokine expression analysis, cells were activated with phorbol 12-myristate 13-acetate (PMA) (0.1 g/ml; Sigma) and ionomycin (0.5 g/ml; Sigma) in RPMI containing 10% FBS and monensin (eBioscience) for 5 hours. For intracellular staining of cytokines and transcription factors, cells were stained with surface markers, fixed in Fix/Perm buffer (eBioscience) for 0.5 to 2 hours, washed twice in permeabilization buffer (eBioscience), and stained with intracellular factors in permeabilization buffer for 30 min on ice. For phosphoprotein staining, cells were fixed with 1.6% paraformaldehyde (Alfa Aesar) for 15 min at 37°C, permeabilized with ice-cold methanol for 1 hour, and stained on ice for 1 hour. For BrdU incorporation analysis, mice were injected with 2 mg of BrdU (Sigma) in phosphate-buffered saline (PBS) intraperitoneally 8 hours ahead of death. After transcription factor staining, cells were incubated in Cytofix/Cytoperm buffer (BD Biosciences) for 10 min at room temperature, washed with Perm/Wash buffer (BD Biosciences), treated with deoxyribonuclease I (650 U/ml; Sigma) for 30 min at 37°C, and stained with anti-BrdU antibody in Perm/Wash buffer for 30 min at room temperature. The chromogranin A (BDC2. , and different concentrations of T regs were activated with anti-CD3 (2 g/ml; BioLegend) in a 96-well round-bottom plate with 100 l of RPMI for 3 days. Suppression was calculated as previously described (47) . Briefly, cells were acquired using BD Fortessa, and the division index (DI) of responder cells was analyzed using FlowJo based on the division of CellTrace Violet. Suppression was then calculated with the following formula: %Suppression = (1 − DI Treg /DI Ctrl ) × 100%, where DI Treg stands for the DI of responder cells with T regs and DI Ctrl stands for the DI of responder cells activated without T regs .
Antibodies and flow cytometry
Gene expression profiling by RNA-seq and bioinformatic analyses T regs (5 × 10 3 ) were sorted from three pooled mice of each group, and cDNAs were prepared using the SMARTer Ultra Low Input RNA Kit for Sequencing version 3 following the user manual (Clontech Laboratories). Sequencing libraries were prepared using the Nextera XT DNA Library Prep Kit (Illumina), normalized to 2 nM using tris-HCl (10 mM; pH 8.5) with 0.1% Tween 20, diluted and denatured to a final concentration of 1.8 nM using the Illumina Denature and Dilute Libraries for the NextSeq 500 protocol Revision D (Illumina). Cluster generation and 75-base pair paired-end dual-indexed sequencing was performed on the Illumina NextSeq 500 system.
The raw reads of RNA-seq were aligned to the mm10 genome using TopHat, and counts were computed relative to the RefSeq transcript annotation file provided in the cufflinks suite (48, 49) . Genes whose mean count value (computed in log 2 space) was below 32 (5 in log 2 space) were removed from further processing, leaving 10,371 total genes. The counts were analyzed for differential expression using DESeq2 with a GC content and length-dependent offset computed by cqn R package (50, 51) .
Pathway analysis
We performed gene set analysis using the Wilcoxon rank-sum test on the differential expression statistic (Wald statistic for the negative binomial coefficient) computed with the DESeq2 package. Significance was assessed with a parametric P value calculation followed by multiple hypothesis correction as well as sample permutation tests. Because there are three replicates of islet T reg samples of each genotype, there are 10 possible ways to divide those into two equal groups, and one of these corresponds to the correct grouping, leaving nine remaining permutations. Pathways that were significant at a false discovery rate of 0.2 but were not significant in any of the possible permutation tests were reported. Principal components analysis was performed using the prcomp R function on the log 2 -transformed normalized counts produced by the DESeq2 counts function with "normalized=T."
Comparisons with Ikzf4-knockdown data set We retrieved processed data from the Gene Expression Omnibus (accession no. GSE17166). Because this data set had no replicates, we used fold change between the Eos small interfering RNA (siRNA) and control siRNA as reference. Genes that had expression levels less than log 2 (intensity) of 5 as well as genes that were affected more than twofold by the control siRNA were excluded from the analysis. The significance of the association between the two transcriptional signatures was assessed using a  2 test on the contingency table summarizing the number of up-or down-regulated genes in si-Ikzf4 T regs and intra-islet T regs . Splenic TCR   +   CD4   +   GFP   +   CD45RB low cells (T regs ) were sorted and activated with PMA (0.1 g/ml; Sigma) and ionomycin (0.5 g/ml; Sigma) with human IL-2 (hIL-2) (500 U/ml; Prometheus) for 2 days and then expanded for another 3 days with hIL-2. WT and Lag3-deficient T regs were mixed at an equal ratio, and 2 × 10 6 total T regs were cotransferred into 6-to 8-week-old WT NODs. T reg recipients were sacrificed and analyzed 4 days after the transfer.
T reg expansion and adoptive transfer
Ikzf4 overexpression and knockdown in T regs
Human IKZF4 open reading frame was amplified from IKZF4-pMIG construct [obtained from C. Benoist ( Sorted splenic T regs were activated with CD3/CD28 Dynabeads (Invitrogen) and hIL-2 (500 U/ml) for 48 hours. Plat-E cells (obtained from H. Chi) were transiently transfected by retroviral vector along with the pCL-Eco helper plasmid (obtained from H. Chi). The viral supernatant was harvested 36 hours after transfection of Plat-E cells and then used for spin transduction of activated T regs with polybrene (6 g/ml; Sigma) at 2000 revolutions per minute for 1 hour. Transduced T regs were sorted 48 hours after transduction, rested for 72 hours, and then restimulated with PMA (0.1 g/ml) and ionomycin (0.5 g/ml) with hIL-2 (500 U/ml) for another 48 hours. BrdU (10 g/ml) was pulsed into T reg culture medium 2 hours before the staining.
Statistical analyses
Experiments were pooled for statistical analyses using Prism version 7 (GraphPad). The log-rank test was applied to Kaplan-Meier survival function estimates to determine the statistical significance of differences in diabetes incidence between experimental groups. Fisher's least significant difference (LSD) test was applied to one-way analysis of variance (ANOVA) to determine the statistical significance in the Ikzf4 overexpression or knockdown experiments. Nonparametric Mann-Whitney test was used in all other instances.
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